{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,28]],"date-time":"2025-11-28T12:00:15Z","timestamp":1764331215554},"reference-count":11,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,6,24]],"date-time":"2023-06-24T00:00:00Z","timestamp":1687564800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,6,24]],"date-time":"2023-06-24T00:00:00Z","timestamp":1687564800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Crit Care"],"DOI":"10.1186\/s13054-023-04538-y","type":"journal-article","created":{"date-parts":[[2023,6,24]],"date-time":"2023-06-24T11:03:17Z","timestamp":1687604597000},"update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Cerebral apolipoprotein E and amyloid precursor-like protein 1 as risk factors for chronic neurodegeneration after non-traumatic acute brain injury (ABI)"],"prefix":"10.1186","volume":"27","author":[{"given":"Carlos A.","family":"Santacruz","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jean-Louis","family":"Vincent","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Virginie","family":"Imbault","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael","family":"Bruneau","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jacques","family":"Creteur","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Serge","family":"Brimioulle","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Raussens","family":"Vincent","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David","family":"Communi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fabio S.","family":"Taccone","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2023,6,24]]},"reference":[{"key":"4538_CR1","doi-asserted-by":"publisher","first-page":"463","DOI":"10.1007\/s12028-022-01507-1","volume":"37","author":"CA Santacruz","year":"2022","unstructured":"Santacruz CA, Vincent JL, Duitama J, Bautista E, Imbault V, Bruneau M, Creteur J, Brimioulle S, Communi D, Taccone FS. The cerebrospinal fluid proteomic response to traumatic and nontraumatic acute brain injury: a prospective study. Neurocrit Care. 2022;37:463\u201370.","journal-title":"Neurocrit Care"},{"issue":"1","key":"4538_CR2","doi-asserted-by":"publisher","first-page":"278","DOI":"10.1186\/s13054-021-03698-z","volume":"25","author":"CA Santacruz","year":"2021","unstructured":"Santacruz CA, Vincent JL, Bader A, Rinc\u00f3n-Guti\u00e9rrez LA, Dominguez-Curell C, Communi D, Taccone FS. Association of cerebrospinal fluid protein biomarkers with outcomes in patients with traumatic and non-traumatic acute brain injury: systematic review of the literature. Crit Care. 2021;25(1):278.","journal-title":"Crit Care"},{"key":"4538_CR3","doi-asserted-by":"publisher","first-page":"1245","DOI":"10.1001\/archneurol.2011.3747","volume":"69","author":"S Shively","year":"2012","unstructured":"Shively S, Scher AI, Perl DP, Diaz-Arrastia R. Dementia resulting from traumatic brain injury: what is the pathology? Arch Neurol. 2012;69:1245\u201351.","journal-title":"Arch Neurol"},{"key":"4538_CR4","doi-asserted-by":"publisher","first-page":"361","DOI":"10.1038\/nrn2808","volume":"11","author":"VE Johnson","year":"2010","unstructured":"Johnson VE, Stewart W, Smith DH. Traumatic brain injury and amyloid-\u03b2 pathology: a link to Alzheimer\u2019s disease? Nat Rev Neurosci. 2010;11:361\u201370.","journal-title":"Nat Rev Neurosci"},{"key":"4538_CR5","doi-asserted-by":"publisher","first-page":"768","DOI":"10.3389\/fcell.2020.00768","volume":"8","author":"YH Yang","year":"2020","unstructured":"Yang YH, Huang LC, Hsieh SW, Huang LJ. Dynamic Blood Concentrations of A\u03b21-40 and A\u03b21-42 in Alzheimer\u2019s Disease. Front Cell Dev Biol. 2020;8:768.","journal-title":"Front Cell Dev Biol"},{"key":"4538_CR6","doi-asserted-by":"publisher","first-page":"23648","DOI":"10.1074\/jbc.M212785200","volume":"278","author":"Y Yoshiike","year":"2003","unstructured":"Yoshiike Y, Chui DH, Akagi T, Tanaka N, Takashima A. Specific compositions of amyloid-beta peptides as the determinant of toxic beta-aggregation. J Biol Chem. 2003;278:23648\u201355.","journal-title":"J Biol Chem"},{"key":"4538_CR7","doi-asserted-by":"publisher","first-page":"5650","DOI":"10.1074\/jbc.M111.264473","volume":"287","author":"K Pauwels","year":"2012","unstructured":"Pauwels K, Williams TL, Morris KL, Jonckheere W, Vandersteen A, Kelly G, Schymkowitz J, Rousseau F, Pastore A, Serpell LC, Broersen K. Structural basis for increased toxicity of pathological a\u03b242:a\u03b240 ratios in Alzheimer disease. J Biol Chem. 2012;287:5650\u201360.","journal-title":"J Biol Chem"},{"key":"4538_CR8","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1016\/j.neuint.2017.08.010","volume":"119","author":"K Ono","year":"2018","unstructured":"Ono K. Alzheimer\u2019s disease as oligomeropathy. Neurochem Int. 2018;119:57\u201370.","journal-title":"Neurochem Int"},{"key":"4538_CR9","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1038\/nrneurol.2012.263","volume":"9","author":"CC Liu","year":"2013","unstructured":"Liu CC, Liu CC, Kanekiyo T, Xu H, Bu G. Apolipoprotein E and Alzheimer disease: risk, mechanisms and therapy. Nat Rev Neurol. 2013;9:106\u201318.","journal-title":"Nat Rev Neurol"},{"key":"4538_CR10","doi-asserted-by":"publisher","first-page":"637","DOI":"10.1161\/01.STR.0000057579.25430.16","volume":"34","author":"A Kay","year":"2003","unstructured":"Kay A, Petzold A, Kerr M, Keir G, Thompson E, Nicoll J. Decreased cerebrospinal fluid apolipoprotein E after subarachnoid hemorrhage: correlation with injury severity and clinical outcome. Stroke. 2003;34:637\u201342.","journal-title":"Stroke"},{"key":"4538_CR11","unstructured":"R Core Team. R: a language and environment for statistical computing. R Foundation for Statistical Computing, Vienna, Austria (2023). https:\/\/www.R-project.org\/."}],"container-title":["Critical Care"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13054-023-04538-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13054-023-04538-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13054-023-04538-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,6,24]],"date-time":"2023-06-24T11:11:37Z","timestamp":1687605097000},"score":1,"resource":{"primary":{"URL":"https:\/\/ccforum.biomedcentral.com\/articles\/10.1186\/s13054-023-04538-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,6,24]]},"references-count":11,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,12]]}},"alternative-id":["4538"],"URL":"https:\/\/doi.org\/10.1186\/s13054-023-04538-y","relation":{},"ISSN":["1364-8535"],"issn-type":[{"value":"1364-8535","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,6,24]]},"assertion":[{"value":"8 May 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 June 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 June 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The original study from which the cohort derived was approved by the Erasme Hospital (Brussels, Belgium) Ethics Committee (2014\/170-2015\/130) and all patients or their next-of-kin signed written informed consent.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"JLV is Editor-in-Chief of Critical Care. He has no other conflicts of interest. The other authors have no conflicts of interest to declare.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"249"}}